People with Parkinson’s disease who participated in a U.K. study said maintaining their oral health helped preserve their independence…
Articles by Andrea Lobo
Georgia has expanded its medical cannabis program, allowing registered patients ages 21 and older to access medical cannabis flower and…
Mighty Therapeutics, a Massachusetts-based biotech company, announced that it has raised $150 million to support the clinical development of…
An investigational stem cell-based therapy that would replace the nerve cells, or neurons, lost due to Parkinson’s disease was…
Kenai Therapeutics has completed patient enrollment in a small, early clinical trial testing the safety and effectiveness of RNDP-001,…
National Football League players had nearly four times the expected mortality rate from neurodegenerative diseases, including Parkinson’s disease, despite having…
Aspen Neuroscience has completed dosing in the third and fourth groups of people with Parkinson’s disease receiving its…
The first meeting of the National Parkinson’s Project Advisory Council, held on June 29, ended with a commitment to…
Many people with advanced Parkinson’s disease may actually not have widespread accumulation of toxic protein clumps known…
The U.S. Food and Drug Administration (FDA) has given Gain Therapeutics a green light to launch a clinical trial —…